Private Equity Value Creation: Strategic Portfolio Growth

A private equity firm makes money on a company in three ways: the company earns more, buyers pay a higher multiple of those earnings at exit, or the company's cash flow pays down the debt used to buy it. For most of the 2010s, rising multiples and cheap debt carried much of the load, and Bain & Company describes a market in which those tailwinds are gone for the foreseeable future.

That mix is harder to repeat. This guide covers the arithmetic behind a buyout's return, how much earnings growth a deal now needs, the operating levers that tend to deliver it, and the ways value creation plans go wrong. For how buyouts are financed, see our leveraged buyout guide; for the first 100 days after closing, see our M&A integration playbook.

The value creation bridge

An illustration with hypothetical numbers: a firm buys a company with $20 million of EBITDA at 11 times, paying $220 million, funded with $88 million of debt (40%) and $132 million of equity. The debt costs 8.5%, and each year the company uses 45% of EBITDA, less interest, to repay it. EBITDA grows 10% a year for five years to $32.2 million, and the company is sold at the same 11 times.

Equity grows from $132 million to $292.5 million, a 2.22 times multiple of money. The same deal under different outcomes:

Each turn of exit multiple moves the result by about a quarter of a turn of equity multiple, which is why a firm that paid a full price has little room for a lower exit multiple.

Why 12% is the new 5%

Bain's 2026 report put this in a rule of thumb. In the 2010s, with rising multiples, a typical deal needed only about 5% annual EBITDA growth to return 2.5 times equity over five years. With borrowing costs of 8% to 9%, debt making up 30% to 40% of the purchase price, and record entry multiples, Bain estimates a typical deal now needs 10% to 12% annual EBITDA growth to reach the same 2.5 times (Bain).

The illustration above reproduces that result. With 40% debt at 8.5% and no change in multiple, the company needs about 12.0% annual EBITDA growth to return 2.5 times. With 60% debt at 5% and an exit at 13 times instead of 11, about 5.0% growth would have done it.

Twelve percent a year for five years nearly doubles EBITDA. Few mature companies can do that organically, which is why current plans lean on pricing, margin work, and add-on acquisitions together.

What the evidence says about operating improvement

A study of 395 buyouts in Western Europe from 1991 to 2007 by Acharya, Gottschalg, Hahn, and Kehoe split average deal returns into parts: about half came from higher leverage, about a sixth from sector returns, and about a third from outperformance relative to public peers. The deals that outperformed most were those with faster sales growth and larger margin improvements than comparable public companies. Partners with operating backgrounds did better in deals focused on internal improvements, while partners with finance backgrounds did better in deals built around acquisitions (Acharya et al.).

Margin plans are also where projections most often miss. In a Bain analysis of 33 software buyouts, 31 had projected a median 560 basis points of margin improvement over a five-year hold, and actual margin growth trailed those plans badly on average (Bain).

Operating levers, with the arithmetic

For a company with $200 million of revenue and a 10% EBITDA margin:

• Pricing. A 1% price increase with no loss of volume adds $2 million of EBITDA, a 10% increase. Pricing projects usually start with discount discipline, since list prices are often less important than the discounts sales teams grant, and with repricing unprofitable customers or contracts.
• Procurement. Cutting purchased costs of $120 million by 2% adds $2.4 million. Consolidating suppliers across add-on acquisitions is a common source.
• Sales effectiveness. Revenue growth from better coverage, pricing, and retention compounds; each $10 million of added revenue at a 30% incremental margin adds $3 million of EBITDA.
• Working capital. Collecting receivables 10 days faster on $200 million of revenue releases about $5.5 million of cash once, which can repay debt. It does not change EBITDA, so it helps the return through the debt line of the bridge.
• Overhead. Shared services across a platform can reduce finance, HR, and IT costs per unit of revenue, but savings projected at acquisition are often slower to arrive than planned.

Every one of these assumes the gain holds. Price increases that drive away customers, supplier changes that disrupt quality, and cost cuts that slow sales can each undo the projected EBITDA.

Buy-and-build

Buying smaller companies at lower multiples and folding them into a platform can create value on paper at closing. An add-on with $3 million of EBITDA bought at 6 times costs $18 million; if the combined company is later valued at 11 times, that EBITDA is worth $33 million, a $15 million gain before any cost savings. The arithmetic only works if the add-ons are integrated, keep their customers, and the platform's multiple holds.

Roll-ups carry regulatory risk. The FTC sued U.S. Anesthesia Partners and its private equity sponsor, Welsh Carson, in 2023, alleging a decade-long scheme to buy up nearly every large anesthesia practice in Texas. Welsh Carson settled in January 2025 with an order limiting its involvement with the company and requiring notice of future acquisitions of hospital-based physician practices (FTC). In April 2026 the FTC reached a confidential agreement in principle with USAP to settle the remaining case (FTC). A buy-and-build plan in a fragmented local market, especially in healthcare, should include antitrust review of the add-on pipeline, not only of each deal.

Building a value creation plan that holds up

A useful plan is short and specific:

1. Start from the diligence findings. Quality of earnings work shows which EBITDA is real; commercial diligence shows where pricing and growth are plausible. Our M&A due diligence guide covers both.
2. List initiatives with an owner, a start date, the expected EBITDA or cash impact, and the one-time cost. Separate what is already contracted from what is hoped for.
3. Test the plan against the return math. If reaching the target return requires every initiative to succeed on time, the price was too high.
4. Tie management equity and bonuses to the measures that drive the bridge, such as EBITDA, cash conversion, and debt reduction, rather than to adjusted figures that are easy to inflate with add-backs.
5. Track results monthly against the plan and drop initiatives that are not working.
6. Prepare for sale early: audited accounts, clean KPI definitions, and a vendor due diligence report reduce the discount buyers apply to uncertain numbers.

Where plans go wrong

• Overpaying. A high entry multiple leaves the return dependent on a multiple that may not be available at exit.
• Too much debt for a rate rise. Valuation Research Corp. found that in loans made in 2021, leverage had risen about 0.9 turns and cash interest coverage fallen about 0.4 turns by early 2026 (VRC).
• Add-backs doing the work. Adjusted EBITDA that relies on projected savings can satisfy lenders at entry and disappoint buyers at exit.
• Long holds. Bain reported buyout holding periods of around seven years in 2025, against five to six years from 2010 to 2021. Every extra year lowers the IRR on the same multiple and delays distributions to investors. Our private equity due diligence guide covers how investors assess a manager's record on this.

For how operating strategy ties to wider business planning, see our guide to AI business strategy.

This guide is for general information and is not investment advice. The deal illustrations use hypothetical numbers and a simplified debt model. Private equity investments are illiquid and carry a risk of loss.